Arena Pharmaceuticals Inc.
Rank 5
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
$63.1000
USD
1.01%
Market cap
$3,143,967,722
Total volume
$31,801,327
Shares outstanding
49,825,162
Rank 5
About
Biopharmaceutical company Arena Pharmaceuticals aims to deliver transformational medicines to patients in the US and Switzerland. The company is involved in several preclinical trials with a focus on ulcerative colitis and Crohn’s disease. Arena Pharmaceuticals has a partnership with Everest Medicines to expand into Asian markets.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
ARNA |
$31,801,327
|
100% |
$63.1000
|
Chart